论文部分内容阅读
目的观察羟基脲(HU)加α-干扰素(α-IFN)治疗慢性粒细胞白血病(CML)慢性期的疗效。方法总结了125例应用羟基脲(HU)加α-干扰素治疗的CML慢性期的疗效及药物的毒副反应。结果羟基脲(HU)加α-干扰素治疗CHR率为96%。结论羟基脲(HU)加α-干扰素(α-IFN)是治疗CML慢性期较为有效的化疗方案。
Objective To observe the curative effect of chronic treatment of chronic myelogenous leukemia (CML) with hydroxyurea (HU) and interferon-α (IFN-α). Methods The clinical efficacy and adverse drug reactions of 125 patients with chronic phase of CML treated with hydroxyurea (HU) plus α-interferon were summarized. Results Hydroxyurea (HU) plus α-interferon treatment of CHR rate of 96%. Conclusions Hydroxyurea (HU) plus interferon-α (IFN-α) is a more effective chemotherapy regimen for the treatment of chronic phase of CML.